AI Summary

Researchers at Charité – Universitätsmedizin Berlin reported that triple therapy, a treatment introduced in 2020 for cystic fibrosis, restores near‑normal function to molecular channels in the mucous membranes of children aged 2 to 11. The study found these early‑childhood patients achieved functional levels almost comparable to healthy individuals after receiving the therapy. This suggests the treatment is especially effective when administered during early childhood.

AI summaries can be wrong sometimes—always verify important details using the source article.